492 related articles for article (PubMed ID: 23835775)
1. Postirradiation otitis media with effusion in nasopharyngeal carcinoma patients treated by intensity-modulated radiotherapy.
Hsin CH; Chen TH; Liang KL; Tseng HC; Liu WS
Laryngoscope; 2013 Sep; 123(9):2148-53. PubMed ID: 23835775
[TBL] [Abstract][Full Text] [Related]
2. Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.
Hsin CH; Tseng HC; Lin HP; Chen TH
Eur Arch Otorhinolaryngol; 2016 Feb; 273(2):471-7. PubMed ID: 25634060
[TBL] [Abstract][Full Text] [Related]
3. A study of middle ear function in the treatment of nasopharyngeal carcinoma with IMRT technique.
Wang SZ; Li J; Miyamoto CT; Chen F; Zhou LF; Zhang HY; Yang G; Wang WF; Guo M; Ni XC; Wang L
Radiother Oncol; 2009 Dec; 93(3):530-3. PubMed ID: 19853315
[TBL] [Abstract][Full Text] [Related]
4. New therapeutic strategy for treating otitis media with effusion in postirradiated nasopharyngeal carcinoma patients.
Kuo CL; Wang MC; Chu CH; Shiao AS
J Chin Med Assoc; 2012 Jul; 75(7):329-34. PubMed ID: 22824047
[TBL] [Abstract][Full Text] [Related]
5. Comparison of otologic complications between intensity-modulated and two-dimensional radiotherapies in nasopharyngeal carcinoma patients.
Hsin CH; Chen TH; Young YH; Liu WS
Otolaryngol Head Neck Surg; 2010 Nov; 143(5):662-8. PubMed ID: 20974336
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of early-stage nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy alone.
Su SF; Han F; Zhao C; Chen CY; Xiao WW; Li JX; Lu TX
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):327-33. PubMed ID: 21035959
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
8. Analysis of anatomical factors controlling the morbidity of radiation-induced otitis media with effusion.
Wang SZ; Wang WF; Zhang HY; Guo M; Hoffman MR; Jiang JJ
Radiother Oncol; 2007 Dec; 85(3):463-8. PubMed ID: 18006095
[TBL] [Abstract][Full Text] [Related]
9. Failure of grommet insertion in post-irradiation otitis media with effusion.
Chen CY; Young YH; Hsu WC; Hsu MM
Ann Otol Rhinol Laryngol; 2001 Aug; 110(8):746-8. PubMed ID: 11510732
[TBL] [Abstract][Full Text] [Related]
10. The treatment for postirradiation otitis media with effusion: a study of three methods.
Xu YD; Ou YK; Zheng YQ; Chen Y; Ji SF
Laryngoscope; 2008 Nov; 118(11):2040-3. PubMed ID: 18818551
[TBL] [Abstract][Full Text] [Related]
11. Irradiated ears in nasopharyngeal carcinoma survivors: A review.
Young YH
Laryngoscope; 2019 Mar; 129(3):637-642. PubMed ID: 30194730
[TBL] [Abstract][Full Text] [Related]
12. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
13. Reirradiation with intensity-modulated radiotherapy for locally recurrent T3 to T4 nasopharyngeal carcinoma.
Chan OS; Sze HC; Lee MC; Chan LL; Chang AT; Lee SW; Hung WM; Lee AW; Ng WT
Head Neck; 2017 Mar; 39(3):533-540. PubMed ID: 27898191
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced hypoglossal nerve palsy after definitive radiotherapy for nasopharyngeal carcinoma: Clinical predictors and dose-toxicity relationship.
Chow JCH; Cheung KM; Au KH; Zee BCY; Lee J; Ngan RKC; Lee AWM; Yiu HHY; Li KWS; Leung AKC; Chan JCH; Lee FKH; Wong KH
Radiother Oncol; 2019 Sep; 138():93-98. PubMed ID: 31252300
[TBL] [Abstract][Full Text] [Related]
15. The effectiveness of myringotomy and ventilation tube insertion versus observation in post-radiation otitis media with effusion.
Charusripan P; Khattiyawittayakun L
Eur Arch Otorhinolaryngol; 2017 Sep; 274(9):3283-3290. PubMed ID: 28540514
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric parameters associated with conductive or sensorineural hearing loss 5 years after intensity-modulated radiation therapy in nasopharyngeal carcinoma.
Zhu W; Chen F; Li J; Wang W; Zhang H; Yang G; Zou L; Zhu Y; Yuan W; Ding H; Song X; Wang S
Acta Otolaryngol; 2019 Mar; 139(3):263-268. PubMed ID: 30870056
[TBL] [Abstract][Full Text] [Related]
17. Eustachian tube function of patients with nasopharyngeal carcinoma.
Hsu MM; Young YH; Lin KL
Ann Otol Rhinol Laryngol; 1995 Jun; 104(6):453-5. PubMed ID: 7771718
[TBL] [Abstract][Full Text] [Related]
18. Postirradiation vertigo in nasopharyngeal carcinoma survivors.
Young YH; Ko JY; Sheen TS
Otol Neurotol; 2004 May; 25(3):366-70. PubMed ID: 15129119
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
20. Middle ear effusions after radiotherapy: correlation with pre-radiotherapy nasopharyngeal tumor patterns.
Kew J; King AD; Leung SF; Tong MC; Ku PK; Wong KK; van Hasselt CA
Am J Otol; 2000 Nov; 21(6):782-5. PubMed ID: 11078063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
